Transobturator Urethral Sling Placement With an Autologous Rectus Facia
NCT ID: NCT03949348
Last Updated: 2021-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
35 participants
INTERVENTIONAL
2016-05-01
2021-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long Term Outcome Women Who Undergone Mid-urethral Sling Surgery
NCT03831217
Efficacy of Mini Sling Versus Transobturator Tape in Surgical Management of Women With Stress Urinary Incontinence
NCT06334848
Midurethral Sling With Autologus Rectus Sheath
NCT03463863
Predictive Role of Urodynamics on Mid-urethral Sling Failure
NCT02337374
Autologous Transobturator Fascia Lata Sling in Treatment of Female Stress Urinary Incontinence
NCT05646745
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Although many clinical trials have demonstrated that synthetic mid-urethral slings are safe, effective and recommended by several guidelines (e.g. Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction/American Urogynecologic Society and American Urologic Association), the safety and efficacy of surgery for SUI using mesh devices has been questioned by a community of patients and clinicians. After Food and Drug Administration notification on mesh use in pelvic surgery, many patients and providers begin to search of different surgery without synthetic mesh alternatives in SUI. Recently, female patients in England formed the campaign group "Sling the Mesh" to protest the synthetic mesh.
Several options such as the autologous pubovaginal sling, biologic grafts, or urethral bulking agent injection have some problems related to morbidity or efficacy. The autologous pubovaginal urethral sling is associated with a higher risk of postoperative voiding dysfunction.
The investigators aimed to demonstrate the feasibility of an autologous transobturator urethral sling to avoid the related problems of synthetic mesh placement and the increased rate of voiding dysfunction with pubovaginal sling placement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
autologous fascia
Patients who underwent a transobturator sling placement using autologous rectus fascia
Mid-urethral sling placement using autologous rectus fascia
Mid-urethral sling placement using autologous rectus fascia
synthetic mesh
Patients who underwent a transobturator sling placement using synthetic mesh
Mid-urethral sling placement using synthetic mesh
Mid-urethral sling placement using synthetic mesh
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mid-urethral sling placement using autologous rectus fascia
Mid-urethral sling placement using autologous rectus fascia
Mid-urethral sling placement using synthetic mesh
Mid-urethral sling placement using synthetic mesh
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* neurologic disorders
* malignancies
* history of radiotherapy
18 Years
75 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Muhammet Fatih Kilinc
Principal invastigator
References
Explore related publications, articles, or registry entries linked to this study.
Linder BJ, Elliott DS. Autologous Transobturator Urethral Sling Placement for Female Stress Urinary Incontinence: Short-term Outcomes. Urology. 2016 Jul;93:55-9. doi: 10.1016/j.urology.2016.03.025. Epub 2016 Mar 29.
Linder BJ, Elliott DS. Autologous transobturator urethral sling placement for female stress urinary incontinence. J Urol. 2015 Mar;193(3):991-6. doi: 10.1016/j.juro.2014.08.125. Epub 2014 Oct 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0635
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.